Corbus Pharmaceuticals Holdings, Inc. - 10-Q Filing
Corbus Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended March 31, 2026, providing updates on financial condition and operations. The filing includes details about recurring fair value measurements of commercial paper, corporate debt securities, money market funds, leasehold improvements as of December 31, 2025, and an open-market sale agreement with Jefferies LLC effective through May 12, 2026.
Tickers: $CRBP